Home > Healthcare > Pharmaceuticals > Disease Specific Drugs > Prostate Cancer Therapeutics Market
Prostate Cancer Therapeutics Market Size
- Report ID: GMI10189
- Published Date: Jul 2024
- Report Format: PDF
Prostate Cancer Therapeutics Market Size
Prostate Cancer Therapeutics Market size was valued at USD 11.7 billion in 2023 and is expected to exhibit growth at a CAGR of 8.8% from 2024 to 2032. High market growth can be attributed to the ongoing advancements in treatment modalities, increasing prevalence of prostate cancer, rising awareness, and screening programs, and expanding pipeline of novel therapies, among other contributing factors.
Moreover, prostate cancer is one of the most prevalent tumors diagnosed in males globally. The aging population, as well as changes in lifestyle factors such as diet, smoking, and physical activity, all contribute to an expansion of prostate cancer incidence and prevalence. For instance, according to the National Institutes of Health (NIH), it is estimated that new cases of prostate cancer will reach 299,010 by 2024 in the U.S. As the number of confirmed cases grows, so does the demand for effective therapeutic options.
Furthermore, public awareness campaigns, educational initiatives, and government-sponsored screening programs raise awareness about prostate cancer risk factors, symptoms, and the importance of early detection. For instance, in August 2023, the George Washington University (GW) Cancer Center launched a prostate cancer awareness campaign. This health awareness social media toolkit could help cancer control organizations use evidence-based strategies to detect prostate cancer. Thus, improved awareness leads to higher rates of screening and diagnosis, driving the demand for prostate cancer therapeutics.
Prostate cancer therapeutics refer to the various treatment options and strategies employed to manage and treat prostate cancer, a malignancy that develops in the prostate gland of males. The aim of prostate cancer therapeutics is to eliminate or manage the cancerous cells, reduce symptoms, improve quality of life, and prolong survival for patients diagnosed with prostate cancer.
| Report Attribute | Details |
|---|---|
| Base Year: | 2023 |
| Prostate Cancer Therapeutics Market Size in 2023: | USD 11.7 Billion |
| Forecast Period: | 2024 to 2032 |
| Forecast Period 2024 to 2032 CAGR: | 8.8% |
| 2032 Value Projection: | USD 24.6 Billion |
| Historical Data for: | 2021 - 2023 |
| No. of Pages: | 110 |
| Tables, Charts & Figures: | 148 |
| Segments covered: | Therapy, Drug Class, Route of Administration, Distribution Channel, and Region |
| Growth Drivers: |
|
| Pitfalls & Challenges: |
|
Frequently Asked Questions (FAQ) :
Prostate Cancer Therapeutics Market Scope
